- Home
- MRK vs PRA Comparison
MRK vs PRA Comparison
Compare MRK & PRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRK
- PRA
- Stock Information
- Founded
- MRK 2000
- PRA 1976
- Country
- MRK United States
- PRA United States
- Employees
- MRK N/A
- PRA N/A
- Industry
- MRK Biotechnology: Pharmaceutical Preparations
- PRA Property-Casualty Insurers
- Sector
- MRK Health Care
- PRA Finance
- Exchange
- MRK Nasdaq
- PRA Nasdaq
- Market Cap
- MRK 218.8B
- PRA 1.2B
- IPO Year
- MRK N/A
- PRA N/A
- Fundamental
- Price
- MRK $84.61
- PRA $24.04
- Analyst Decision
- MRK Buy
- PRA Hold
- Analyst Count
- MRK 15
- PRA 4
- Target Price
- MRK $105.14
- PRA $21.00
- AVG Volume (30 Days)
- MRK 13.0M
- PRA 428.0K
- Earning Date
- MRK 10-30-2025
- PRA 11-06-2025
- Dividend Yield
- MRK 3.82%
- PRA N/A
- EPS Growth
- MRK 20.41
- PRA N/A
- EPS
- MRK 6.49
- PRA 0.95
- Revenue
- MRK $63,616,000,000.00
- PRA $1,128,928,000.00
- Revenue This Year
- MRK $1.84
- PRA N/A
- Revenue Next Year
- MRK $5.24
- PRA N/A
- P/E Ratio
- MRK $13.07
- PRA $25.34
- Revenue Growth
- MRK 1.82
- PRA N/A
- 52 Week Low
- MRK $73.31
- PRA $13.00
- 52 Week High
- MRK $110.19
- PRA $24.22
- Technical
- Relative Strength Index (RSI)
- MRK 50.44
- PRA 55.74
- Support Level
- MRK $86.20
- PRA $23.91
- Resistance Level
- MRK $85.50
- PRA $24.07
- Average True Range (ATR)
- MRK 2.34
- PRA 0.10
- MACD
- MRK -0.25
- PRA -0.01
- Stochastic Oscillator
- MRK 49.31
- PRA 37.50
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About PRA ProAssurance Corporation
ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.